Newsfeeds - Spark Newswire

1 minute read

Geron Stock Trading Is Higher On Reinforcing Imetelstat’s Approach For Myelofibrosis Treatment, With Data Publication In Journal

Today, 4:06 PM

Geron Corporation (NASDAQ:GERN) stock is trading higher during the premarket in reaction to data publication from the IMbark Phase 2…

GERN

2 minute read

FDA
News

Geron Announces Publication Of IMbark Phase 2 Data In Journal Of Clinical Oncology

By Benzinga Newsdesk

Today, 4:06 PM

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced the publication of data from the IMbark Phase 2 clinical trial in the Journal of Clinical Oncology in a paper

GERN

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

Today, 4:06 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

6 minute read

Uncategorized

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

By Shanthi Rexaline

Today, 4:06 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)

ABBV

13 minute read

Uncategorized

Earnings Scheduled For May 10, 2021

By Benzinga Insights

Today, 4:06 PM

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.

ACEL

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 4:06 PM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL

Latest news

Geron Stock Trading Is Higher On Reinforcing Imetelstat’s Approach For Myelofibrosis Treatment, With Data Publication In Journal

Geron Announces Publication Of IMbark Phase 2 Data In Journal Of Clinical Oncology

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

Earnings Scheduled For May 10, 2021

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings